Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes

被引：65

作者：

Ayyala, RS

Cruz, DA

Margo, CE

Harman, LE

Pautler, SE

Misch, DM

Mines, JA

Richards, DW

机构：

[1] Univ S Florida, Inst Eye, Dept Ophthalmol, Tampa, FL 33612 USA

[2] Watson Clin, Dept Ophthalmol, Lakeland, FL USA

[3] Retina Vitreous Associates Florida, Tampa, FL USA

[4] Vitreous & Retina Consultants PA, Winter Haven, FL USA

[5] Bay Area Retina Consultants, Clearwater, FL USA

[6] Univ Glaucoma Ctr, Tampa, FL USA

来源：

AMERICAN JOURNAL OF OPHTHALMOLOGY | 1998年 / 126卷 / 04期

关键词：

D O I：

10.1016/S0002-9394(98)00127-5

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

PURPOSE: To describe four patients who developed cystoid macular edema shortly after onset of treat ment with latanoprost, METHOD: Retrospective review of medical records of patients with open-angle glaucoma who developed cystoid macular edema shortly after starting latanoprost. RESULTS: The use of topical latanoprost was temporally related to the development of cystoid macular edema in four patients (six eyes; two aphakic eyes and four pseudophakic eyes). Cystoid macular edema resolved in all patients after latanoprost was discontinued, CONCLUSIONS: Cystoid macular edema is a potential complication of latanoprost therapy. Further observations are needed to determine if the risk of cystoid macular edema is limited to or greatest in patients who are pseudophakic or aphakic, (Am J Ophthalmol 1998;126:602-604.. (C) 1998 by Elsevier Science Inc. All rights reserved.).

引用

页码：602 / 604

页数：3

共 5 条

[1] Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma - A six-month, masked, multicenter trial in the United States [J].

Camras, CB ;

Cioffi, GA ;

VanBuskirk, EM ;

Fraser, J ;

Stewart, WC ;

Stewart, JA ;

Lustgarten, J ;

Schumer, RA ;

Podos, SM ;

Arroyo, M ;

Nitzberg, S ;

Ritch, R ;

Abundo, G ;

Caronia, R ;

Liebmann, J ;

Steinberger, D ;

Krupin, T ;

Rosenberg, LF ;

Ruderman, JM ;

Clarkson, K ;

Weinreb, RN ;

Ochabsi, R ;

Sherwood, M ;

Smith, MF ;

Stokes, DW ;

Zam, ZS ;

Wilensky, J ;

Hillman, D ;

Kaplan, B ;

Gates, V ;

Nail, C ;

Zimmerman, T ;

Fechtner, R ;

Fenton, R ;

Fenton, J ;

Higginbotham, EJ ;

Johnson, AT ;

PollackRundle, CJ ;

Weiss, E ;

Yablonski, ME ;

Tannenbaum, MH ;

Ibrahim, F ;

Ohia, E ;

Neely, D ;

Minckler, D ;

Heuer, D ;

Lee, P ;

Padea, M ;

Kaufman, PL ;

Heatley, GA .

OPHTHALMOLOGY, 1996, 103 (01) :138-147

[2]

PEYMAN G A, 1975, Annals of Ophthalmology, V7, P279

[3] Adverse side effects associated with latanoprost [J].

Rowe, JA ;

Hattenhauer, MG ;

Herman, DC .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 124 (05) :683-685

[4] Cystoid macular edema and anterior uveitis associated with latanoprost use -: Experience and incidence in a retrospective review of 94 patients [J].

Warwar, RE ;

Bullock, JD ;

Ballal, D .

OPHTHALMOLOGY, 1998, 105 (02) :263-268

[5] A six-month, randomized, double masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension [J].

Watson, P ;

Stjernschantz, J ;

Beck, L ;

Blackmore, M ;

Coakes, R ;

Reynolds, P ;

Davey, C ;

HickmanCasey, J ;

Elkington, A ;

Luff, A ;

Green, F ;

Valenzuela, F ;

Longstaff, S ;

Currie, Z ;

Mills, B ;

Chatterjee, A ;

Murray, S ;

Nagasubramanian, S ;

Potts, M ;

Spencer, I ;

Roxburgh, S ;

Sanders, R ;

Bailey, M ;

Vernon, S ;

Sloper, M ;

Wishart, P ;

Birch, M .

OPHTHALMOLOGY, 1996, 103 (01) :126-137

← 1 →